Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,300 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted February 16, 2017
U.S. Department of Justice Files Permanent Injunction Against Supplement Manufacturer
At the time the complaint was filed, Pick and Pay agreed to be bound to a consent decree (which is currently awaiting judicial approval) to stop all production and distribution of its products. The decree will also require the company to recall and destroy remaining products.
According to the complaint, FDA inspections of Pick and Pay facilities between 2012 and 2016 found the company failed to ensure the identity, purity, strength and composition of their finished products, a violation of Current Good Manufacturing Practices for dietary supplements. The FDA issued a warning letter to the company in 2015 for this and other violations, including failure to make and keep documentation of calibrations for instruments used in the manufacturing or testing dietary supplements, and failure to adequately install and maintain plumbing to avoid being a source of contamination to components, dietary supplements and its water supplies.
The complaint also alleged Pick and Pay marketed and promoted its products for the prevention and treatment of diseases such as cancer, cardiovascular disease and multiple sclerosis -- claims which are not permitted for dietary supplements.
Pick and Pay will be required to obtain written approval from the FDA that they appear to be in compliance with remedial measures provided in the consent decree in order to resume manufacturing.
See ConsumerLab.com's Reviews of Calcium Supplements and Potassium Supplements for tests of related products.
See Related Warnings:
Seller of Magnesium, Calcium, Silver and More Warned for Manufacturing Violations, Drug Claims
Federal Court Orders Dietary Supplement Distributor to Stop Selling Its Products
Federal Court Shuts Down Seller of Supplement Promoted for Herpes
To read the U.S. Department of Justice's complete news release, use the link below.
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
